ropivacaine has been researched along with Benign Supratentorial Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gazoni, FM; Nemergut, EC; Pouratian, N | 1 |
| Fermanian, C; Fischler, M; Law-Koune, JD; Liu, N; Peuch, C; Szekely, B | 1 |
2 trial(s) available for ropivacaine and Benign Supratentorial Neoplasms
| Article | Year |
|---|---|
Effect of ropivacaine skull block on perioperative outcomes in patients with supratentorial brain tumors and comparison with remifentanil: a pilot study.
Topics: Adult; Amides; Anesthetics, Intravenous; Anesthetics, Local; Blood Pressure; Craniotomy; Humans; Intracranial Pressure; Nerve Block; Pilot Projects; Piperidines; Prospective Studies; Remifentanil; Ropivacaine; Scalp; Single-Blind Method; Supratentorial Neoplasms; Treatment Outcome | 2008 |
Scalp infiltration with bupivacaine plus epinephrine or plain ropivacaine reduces postoperative pain after supratentorial craniotomy.
Topics: Adult; Aged; Amides; Anesthesia, Local; Anesthetics, Local; Bupivacaine; Craniotomy; Double-Blind Method; Drug Combinations; Epinephrine; Female; Humans; Male; Middle Aged; Pain Measurement; Pain, Postoperative; Prospective Studies; Ropivacaine; Scalp; Supratentorial Neoplasms; Vasoconstrictor Agents | 2005 |